Therapeutic Advances in Infectious Disease

Aims & Scope

Therapeutic Advances in Infectious Disease delivers the highest quality peer-reviewed, open access, original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of infectious diseases.

This includes articles examining the social determinants of health.

The journal is aimed at an international audience of clinicians, researchers, and students/trainees in infectious disease and related disciplines (including infection control), providing an online forum for rapid dissemination of recent research and perspectives in this area.

The journal welcomes unsolicited article proposals.

Review articles include expert opinion/perspective, narrative reviews and therapeutic area reviews.

Systematic reviews, meta-analyses, post-marketing and health economic and pharmacoeconomic reviews are also welcomed.

The appropriate EQUATOR Network reporting guidelines should be followed (e.g.

CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses).

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,800.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Carbapenem resistance: overview of the problem and future perspectives

  Citation: 298

  Authors: Georgios

• The role of nanotechnology in the treatment of viral infections

  Citation: 172

  Authors: Lavanya, Hendrik G., Glenn E.M., Thavendran, Raveen

• Recent advances in the understanding of antibiotic resistance in <i>Clostridium difficile</i> infection

  Citation: 150

  Authors: Patrizia

• The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management

  Citation: 100

  Authors: Margaret, Ishmael, Emilia de, Jeffrey M., David M.

• Extrahepatic manifestations of chronic hepatitis C virus infection

  Citation: 96

  Authors: Patrice, Cloe, Fanny, Léa, Anne C., David

• <i>Blastocystis</i>, an unrecognized parasite: an overview of pathogenesis and diagnosis

  Citation: 93

  Authors: Ivan, Philippe, Eric, Meloni, Catherine, Frédéric, Hicham El

• COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review

  Citation: 80

  Authors: Sonia, Sara J., Vicente, Juthaporn

• Extrapulmonary tuberculosis: are statistical reports accurate?

  Citation: 62

  Authors: Ekaterina

• Respiratory syncytial virus: diagnosis, prevention and management

  Citation: 60

  Authors: Rachael, Christopher A., Charles J., Simon B.

• The emerging SARS-CoV-2 variants of concern

  Citation: 58

  Authors: Adekunle, Chuku, Aleksandra, Nafees, Abu Fahad, Urooj, Stephanie, Vyshnavy